Case Reports in Neuro-Oncology: 2026

This Research Topic represents a dedicated Case Reports in Neuro-Oncology collection within Frontiers in Oncology. It builds on the success of previous case-based collections and serves as a continuation of this initiative. This Research Topic is the second volume of “Case Reports in Neuro-Oncology: 2022.”The collection aims to bring together original and clinically meaningful Case Reports focused on neuro-oncological diseases, including primary and secondary central nervous system tumors. This collection focuses on adult neuro-oncology cases and therefore does not include paediatric case reports. All Case Reports submitted to this collection will be personally assessed by a senior Associate Editor before the initiation of peer review to ensure suitability, originality, and clinical relevance.Case Reports should highlight unique or educational clinical scenarios, including (but not limited to):Rare neuro-oncological cases with typical clinical or pathological features.Common neuro-oncological conditions presenting with atypical features, disease courses, or responses.Convincing responses to novel or emerging therapeutic approaches, including carefully justified off-label treatments.Only submissions that are original and provide a meaningful contribution to the field of neuro-oncology will be considered.Case Report format requirements:- Maximum word count: 3,000 words- Title: Case Report: “Area of focus”- Abstract- Introduction: outlining what makes the case unique, supported by relevant literature- Case description: including de-identified patient information, clinical presentation, diagnostic findings, prior interventions, and outcomes- Figure or table: presenting a clear timeline of key clinical events- Diagnostic assessment and therapeutic intervention: including follow-up and outcomes, in accordance with the CARE (CAse REport) reporting guidelines for clinical case reports- Discussion: strengths and limitations of the approach, comparison with relevant literature, and key take-home messages- Patient perspective, where appropriateImportant note: Authors are required to obtain written informed consent from the patients (or their legal representatives) for publication. Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent clinical or patient cohort, or biological validation in vitro or in vivo) are not suitable for publication in this journal. Topic editors: Brian D Adams, Supriya Mallick, Ignazio Gaspare Vetrano Source: https://www.frontiersin.org/research-topics/78072/case-reports-in-neuro-oncology-2026